Charles Gleason

3.1k total citations
7 papers, 97 citations indexed

About

Charles Gleason is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Charles Gleason has authored 7 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Charles Gleason's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (2 papers). Charles Gleason is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (2 papers). Charles Gleason collaborates with scholars based in United States and Argentina. Charles Gleason's co-authors include Viviana Simon, Judith A. Aberg, Hiromi Muramatsu, Juan Manuel Carreño, Komal Srivastava, Florian Krammer, Johnstone Tcheou, Rachel L. Miller, Gagandeep Singh and Norbert Pardi and has published in prestigious journals such as Nucleic Acids Research, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Charles Gleason

6 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Gleason United States	4	58	49	22	12	10	7	97
Johnstone Tcheou United States	4	51 0.9×	46 0.9×	24 1.1×	12 1.0×	7 0.7×	5	96
Komal Srivastava United States	6	50 0.9×	57 1.2×	21 1.0×	12 1.0×	4 0.4×	13	120
Jinyan Zhang Singapore	5	52 0.9×	69 1.4×	18 0.8×	3 0.3×	4 0.4×	18	153
Kendall A. Lundgreen United States	2	45 0.8×	112 2.3×	53 2.4×	11 0.9×	4 0.4×	2	148
Nicole P. Hachmann United States	4	83 1.4×	27 0.6×	26 1.2×	3 0.3×	10 1.0×	5	106
Gina Cusimano United States	4	66 1.1×	57 1.2×	54 2.5×	2 0.2×	5 0.5×	5	134
Daniel Louiselle United States	7	101 1.7×	53 1.1×	25 1.1×	3 0.3×	3 0.3×	10	171
Chengcheng Fan United States	6	45 0.8×	64 1.3×	12 0.5×	2 0.2×	10 1.0×	9	134
Jiazhen Yu China	5	25 0.4×	28 0.6×	5 0.2×	7 0.6×	7 0.7×	8	64
Mircea Gabriel Stoleriu Germany	5	44 0.8×	121 2.5×	16 0.7×	13 1.1×	7 0.7×	15	200

Countries citing papers authored by Charles Gleason

Since Specialization

Citations

This map shows the geographic impact of Charles Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Gleason more than expected).

Fields of papers citing papers by Charles Gleason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Gleason. The network helps show where Charles Gleason may publish in the future.

Co-authorship network of co-authors of Charles Gleason

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Gleason. A scholar is included among the top collaborators of Charles Gleason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Gleason. Charles Gleason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gleason, Charles, John F. Crary, Lusheng Song, et al.. (2025). Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myeloma. Haematologica. 111(1). 431–435. 1 indexed citations

2.

Gleason, Charles, Sandra Terry, Matthew M. Hernandez, et al.. (2025). An integrated approach for the accurate detection of HERV-K HML-2 transcription and protein synthesis. Nucleic Acids Research. 53(2).

3.

Klingler, Jéromine, Shreyas Kowdle, Juan C. Bandrés, et al.. (2024). Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities. Frontiers in Immunology. 15. 1382619–1382619. 1 indexed citations

4.

Singh, Gagandeep, Anass Abbad, Johnstone Tcheou, et al.. (2023). Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections. The Journal of Infectious Diseases. 228(5). 564–575. 4 indexed citations

5.

Carreño, Juan Manuel, Gagandeep Singh, Johnstone Tcheou, et al.. (2022). mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations. Vaccine. 40(42). 6114–6124. 62 indexed citations

6.

Klingler, Jéromine, Juan C. Bandrés, Arthur Nádas, et al.. (2022). Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients. iScience. 25(12). 105608–105608. 3 indexed citations

7.

Klingler, Jéromine, Vincenza Itri, Sean Liu, et al.. (2021). Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals. Frontiers in Immunology. 12. 759688–759688. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact